The advent of massively parallel sequencing by next generation sequencing platforms now allow genomic approaches for individualizing healthcare. Genomic sequencing data reveals variants in genes related to drug metabolism that may affect efficacy or response. This presentation will describe the potential of NGS data for companion diagnostics or therapeutics and its implementation into clinical laboratories. Evaluating pharmacogenetic targets through exome analysis as well as through targeted gene panels will be discussed.
Routine coagulation assays are widely performed in laboratories and provide valuable information to the patient’s overall clinical picture. It’s important for laboratorians to kn...
Quality efforts in the clinical laboratory are always under the microscope- a hyper-focus for laboratorians from start to finish. Recognizing the external factors that affect hemostasis test...
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Join this year's poster presenters in the Poster Hall during the Poster Networking Hour, Wednesday, September 20th, from 10:00 AM –11:00 AM PDT , to chat live about their posters a...
Loading Comments...
Please update your information
Certificate of Attendance
Thank you for choosing Labroots. Please note that a Certificate of Attendance does NOT count towards Continuing Education Credits.